N/A
Completed N=26
Community Empowerment to Pilot a Novel Device for Monitoring Rescue Medication Use in Urban Children With Asthma
Source: ClinicalTrials.gov NCT02517047 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Apr 2018
Primary outcomePrimary: Number of Participants With Daily Medication Compliance — 24 Participants
Summary
Background: Pediatric asthma is the most common chronic illness among children and is associated with poor quality of life, activity restriction, school absences, and thousands of physician visits annually. The purpose of this study is to measure the effectiveness of using an innovative tracking system (CareTRx) for the self-management of asthma, including daily and rescue medication use, among children and adolescents with pediatric asthma.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Daily Medication Compliance |
24 | — |
| PRIMARY Number of Participants With Rescue Inhaler Use |
24 | — |
| SECONDARY Asthma Symptoms |
21.6 | — |
| SECONDARY Forced Expiratory Volume |
1.56 | — |
Eligibility Criteria
Inclusion Criteria
- Youth with a primary diagnosis of persistent asthma according by NHLBI criteria
- Females or males between the ages of 6-17 years of age
- Youth or caregiver must have an Android smart phone with operating system 4.3 or above and data plan for the duration of the study period
Exclusion Criteria
- Youth with other cardiac, pulmonary, or neuromuscular disorders that impact breathing
- Youth with documented developmental delays or impairments that would interfere with ability to use CareTRx system
Data sourced from ClinicalTrials.gov (NCT02517047). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.